Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05OWB
|
|||
| Former ID |
DIB006504
|
|||
| Drug Name |
mab-216
|
|||
| Synonyms |
Human monoclonal antibody (B-cell acute lymphoblastic leukemia), Stanford University
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | leukaemia [ICD-11: 2A60-2B33; ICD-9: 208.9] | Phase 1 | [1] | |
| Company |
Stanford University
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00313053) Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.